Vaxxinity Inc (VAXX)
0.05
-0.04
(-44.44%)
USD |
OTCM |
Sep 18, 15:14
Vaxxinity Total Assets (Quarterly): 44.31M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.31M |
| September 30, 2023 | 57.48M |
| June 30, 2023 | 71.37M |
| March 31, 2023 | 85.53M |
| December 31, 2022 | 106.40M |
| September 30, 2022 | 122.96M |
| Date | Value |
|---|---|
| June 30, 2022 | 137.00M |
| March 31, 2022 | 147.53M |
| December 31, 2021 | 166.67M |
| September 30, 2021 | 134.92M |
| June 30, 2021 | 141.89M |
| December 31, 2020 | 50.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.31M
Minimum
Dec 2023
166.67M
Maximum
Dec 2021
105.52M
Average
114.68M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.90M |
| Shareholders Equity (Quarterly) | 13.41M |